Schrodinger (NASDAQ:SDGR) CEO Ramy Farid Sells 3,661 Shares

Schrodinger, Inc. (NASDAQ:SDGR) CEO Ramy Farid sold 3,661 shares of the stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $12.91, for a total transaction of $47,263.51. Following the sale, the chief executive officer directly owned 330,824 shares of the company’s stock, valued at approximately $4,270,937.84. This represents a 1.09% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Schrodinger Price Performance

Shares of NASDAQ:SDGR traded down $0.29 on Friday, reaching $12.74. 976,433 shares of the company traded hands, compared to its average volume of 1,475,655. The stock has a market capitalization of $938.56 million, a PE ratio of -8.97 and a beta of 1.57. The company’s 50 day moving average is $14.88 and its 200-day moving average is $17.65. Schrodinger, Inc. has a fifty-two week low of $11.11 and a fifty-two week high of $27.63.

Schrodinger (NASDAQ:SDGR) last announced its earnings results on Wednesday, February 25th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of ($0.13) by $0.57. The business had revenue of $87.24 million during the quarter, compared to the consensus estimate of $83.66 million. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.Schrodinger’s revenue was up 4.7% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.24) earnings per share. As a group, analysts expect that Schrodinger, Inc. will post -2.37 EPS for the current year.

Schrodinger News Roundup

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
• Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
• Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
• Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
• Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

Analysts Set New Price Targets

Several research firms have weighed in on SDGR. TD Cowen reiterated a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. Bank of America raised Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 target price on the stock in a research report on Monday, December 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Schrodinger in a report on Friday, January 9th. Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Finally, KeyCorp decreased their target price on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, January 8th. Four research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Schrodinger has an average rating of “Hold” and an average price target of $21.75.

Institutional Investors Weigh In On Schrodinger

A number of hedge funds have recently bought and sold shares of SDGR. Massachusetts Financial Services Co. MA raised its stake in Schrodinger by 38.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock valued at $41,573,000 after purchasing an additional 577,899 shares during the last quarter. Capital Fund Management S.A. bought a new position in shares of Schrodinger during the 2nd quarter worth about $1,486,000. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Schrodinger by 24.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock valued at $91,365,000 after buying an additional 904,619 shares during the last quarter. Nikko Asset Management Americas Inc. lifted its stake in shares of Schrodinger by 7.2% in the second quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock valued at $52,089,000 after buying an additional 174,684 shares during the period. Finally, Citigroup Inc. grew its position in Schrodinger by 122.5% during the third quarter. Citigroup Inc. now owns 155,209 shares of the company’s stock worth $3,113,000 after buying an additional 85,448 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Schrodinger Company Profile

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.